Dr. Glenn S. Turett, MD

Dr. Turett practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Dr. Turett's NPI, 1659409035, was assigned on February 28, 2007. Dr. Turett graduated from Icahn School Of Medicine At Mount Sinai in 1985. Dr. Turett holds New York license 169376.

Dr. Turett's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Dr. Turett's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Turett to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Turett practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Turett's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Turett is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Turett's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acute skin infection, endocarditis, hiv/aids, joint or bone infection, lyme disease, pneumonia and UTI among the conditions Dr. Turett treats.

CMS data shows 405 Medicare services from Dr. Turett across 12 procedure codes in 2024, for 225 Medicare patients. Medicare paid $37,906 for them.

CMS counts 225 Medicare patients who saw Dr. Turett in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Turett's median patient age at 68, with 41% women.

In 2024, Dr. Turett wrote 1,295 Medicare Part D claims for 139 patients. 27% of them were for generic drugs. CMS names the drug for 1,160 of them, across 23 drugs with 11 or more claims each, at $3,500,183 in total drug cost. In 2023, CMS named 1,107 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Turett for performance year 2024, reported through an alternative payment model (APM). Dr. Turett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Turett as offering telehealth.

Dmand AI links 14 papers to Dr. Turett, published from 2015 to 2023. 2022 was the busiest year, with 2. The most frequent topics are AIDS-Related Opportunistic Infections, Anti-Bacterial Agents and Antitubercular Agents. Dr. Turett has published most often in IDCases. Dr. Turett's most frequent co-authors are Sorana Segal-Maurer, MD, Nishant Prasad, MD and Barkat Ali Fazal, MD.

CMS Open Payments shows 650 general payments to Dr. Turett from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. ViiV Healthcare Company paid the most, $143,079.

Dmand AI lists 2 awards for Dr. Turett, most recently NCQA PCMH in 2015.

Dr. Turett graduated from Icahn School Of Medicine At Mount Sinai in 1985.

Dr. Turett is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.